← Leaderboards
John S Welch
Washington University
$3,417,177
Attributed
$3,980,047
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $761.3K · FY2010–21$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$3,980,047 · 4
By mechanism
R01$3,031,990 · 2
R00$705,417 · 1
K99$242,640 · 1
Top collaborators
- Marina Y Konopleva3 shared
Most similar at Washington University
Same institution · by research overlap
- Timothy J Ley$36,060,228
- John F Dipersio$33,235,840
- Lukas D Wartman$768,495
- Jeffery M Klco$4,840,390
- Matthew Christopher$688,645
Others in their field
Top investigators on “Leukemia”
- Richard K. Wilson · Washington University$209,620,938
- David Heimbrook · Leidos Biomedical Research, Inc.$168,419,678
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,967,203
- Peter C Adamson · National Childhood Cancer Foundation$143,910,899
- Ralph Parchment · Leidos Biomedical Research, Inc.$141,315,269
- Richard L Schilsky · University Of Chicago$129,102,207
Research focus
LeukemiaBaseStem CellsTranscription FactorMyelogenousLigandsHemolytic AnemiaIn VivoSelf-RenewalTranscription CoactivatorPathologicPhysiologicalReporterRegulationRetinoid ReceptorRetinoidsHematopoiesisHematopoieticAcute Promyelocytic LeukemiaVitamin ARecoveryPharmaceutical PreparationsResistanceCells
Grant awards (13)
Targeting apoptosis in high-risk AML and MDS with BCL-2 inhibitor Venetoclax and optimized 10-day Decitabine regimen$374,788
R01 · FY2021 · CA
RETINOIDS IN HEMATOPOIESIS$381,250
R01 · FY2020 · HL · contact PI
Targeting apoptosis in high-risk AML and MDS with BCL-2 inhibitor Venetoclax and optimized 10-day Decitabine regimen$370,892
R01 · FY2020 · CA
RETINOIDS IN HEMATOPOIESIS$381,250
R01 · FY2019 · HL · contact PI
Targeting apoptosis in high-risk AML and MDS with BCL-2 inhibitor Venetoclax and optimized 10-day Decitabine regimen$380,060
R01 · FY2019 · CA
RETINOIDS IN HEMATOPOIESIS$381,250
R01 · FY2018 · HL · contact PI
RETINOIDS IN HEMATOPOIESIS$381,250
R01 · FY2017 · HL · contact PI
RETINOIDS IN HEMATOPOIESIS$381,250
R01 · FY2016 · HL · contact PI
Retinoids in Hematopoiesis$228,413
R00 · FY2014 · HL · contact PI
Retinoids in Hematopoiesis$228,005
R00 · FY2013 · HL · contact PI
Retinoids in Hematopoiesis$248,999
R00 · FY2012 · HL · contact PI
Retinoids in Hematopoiesis$121,414
K99 · FY2011 · HL · contact PI
Retinoids in Hematopoiesis$121,226
K99 · FY2010 · HL · contact PI